Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Athenex Pharma Solutions, LLC
EIR
•Athenex Pharma Solutions, LLC•March 12, 2020

Athenex Pharma Solutions, LLC – FDA EIR, Mar 12, 2020

Record Details

An FDA pre-approval inspection was conducted at Athenex Pharma Solutions, LLC in Clarence, NY, from March 11-12, 2020. The inspection focused on the company's manufacturing operations for New Drug Application (NDA) 213189, Tirbanibulin ointment, 1%, a non-sterile commercial drug product, under the Compliance Program Guidance Manual 7346.832. While no FDA Form 483 for objectionable conditions was issued, verbal observations were discussed with management. These included concerns about document control, deficiencies in documentation practices—specifically the lack of clear mechanisms to identify original issuance or controlled usage of release testing results and ambiguous identification of personnel performing calculations. Additionally, the adequacy of reviewing investigations from third-party laboratories was highlighted, noting the approval of an Out-of-Specification result closure without full data verification or confirmed root cause. The company's operations are subject to Current Good Manufacturing Practices (21 CFR Parts 210/211) and pre-market approval requirements (21 CFR Part 314). Management committed to evaluating and implementing voluntary corrective and preventive actions (CAPAs) to address these observations, with the FDA emphasizing that failure to do so could lead to further regulatory actions. The final classification of the inspection remains at the discretion of the FDA's compliance branch.

Company
Athenex Pharma Solutions, LLC
Inspection date
March 12, 2020
Product type
drugs
Office
Office of Pharmaceutical Quality Operations Division I
Person
  • Patric C. Klotzbuecher
View Company Profile

ID · b612812a-55fb-4846-bec0-5ea13d871b57

Violation Codes4
21 CFR 21121 CFR 820.10021 CFR 21021 CFR 314

Full citation text and observation details available on the Dashboard.

Other documents for Athenex Pharma Solutions, LLC
  • 483 - 2022-09-16September 16, 2022
  • 483 - 2019-08-28August 28, 2019
  • 483 - 2017-12-13December 13, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Athenex Pharma Solutions, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.